Chase Templeton has signalled its intention to maintain an aggressive acquisition momentum by strengthening its Board.
The private medical insurance specialist has appointed former finance director Jeff Tate mergers and acquisitions director and added that "buy and build" will remain at the heart of Chase Templeton's growth strategy for the foreseeable future.
Taking his place as finance director is Jamie McGivern, who steps up from his role as financial analyst which he took when joining the company last year.
The remodelling of the boardroom follows a period of acquisition activity which added £9.4m annual premium income (API) to its books within just the last two months.
Warren Dickson, chief executive officer (pictured), said: "We have a highly successful and proven model that benefits brokers, consultants and IFAs keen to exit or partially exit an increasingly bureaucratic and heavily regulated sector.
"They are rewarded through receipt of a prompt and fair settlement of their business's value whilst we benefit from the added value we can then build from our purchases.
"We will therefore continue to pro-actively seek out further acquisitions going forward."
The move was also welcomed by Palatine Private Equity which has backed the business since February 2013.
Ed Fazakerley, partner at Palatine Private Equity, said: "The business has successfully delivered a buy and build strategy and continues to show a strong trading performance. We are keen for the company to identify new growth prospects and make new acquisitions, which will further strengthen profits over the coming months."